Quality of Life in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia on Imatinib Versus Interferon Alfa Plus Low-Dose Cytarabine: Results From the IRIS Study von HAHN, Elizabeth A, GLENDENNING, G. Alastair, CELLA, David, SORENSEN, Mark V, HUDGENS, Stacie A, DRUKER, Brian J, GUILHOT, Francois, LARSON, Richard A, O'BRIEN, Stephen G, DOBREZ, Deborah G, HENSLEY, Martee L

Volltext

Health-Related Quality of Life among Patients with Breast Cancer Receiving Zoledronic Acid or Pamidronate Disodium for Metastatic Bone Lesions von Weinfurt, Kevin P., Liana D. Castel, Li, Yun, Justin W. Timbie, G. Alastair Glendenning, Schulman, Kevin A.

Volltext

Development and validation of the living with chronic obstructive pulmonary disease questionnaire von McKenna, Stephen P., Meads, David M., Doward, Lynda C., Twiss, James, Pokrzywinski, Robin, Revicki, Dennis, Hunter, Cameron J., Glendenning, G. Alastair

Volltext

Cost‐effectiveness of imatinib versus interferon‐α plus low‐dose cytarabine for patients with newly diagnosed chronic‐phase chronic myeloid leukemia von Reed, Shelby D., Anstrom, Kevin J., Ludmer, Jennifer A., Glendenning, G. Alastair, Schulman, Kevin A.

Volltext

Using Multiple Anchor- and Distribution-Based Estimates to Evaluate Clinically Meaningful Change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BR... von Yost, Kathleen J., Sorensen, Mark V., Hahn, Elizabeth A., Glendenning, G. Alastair, Gnanasakthy, Ari, Cella, David

Volltext

Development and validation of the Asthma Life Impact Scale (ALIS) von Meads, David M, McKenna, Stephen P, Doward, Lynda C, Pokrzywinski, Robin, Revicki, Dennis, Hunter, Cameron, Glendenning, G. Alastair

Volltext

Long‐term survival estimates for imatinib versus interferon‐α plus low‐dose cytarabine for patients with newly diagnosed chronic‐phase chronic myeloid leukemia von Anstrom, Kevin J., Reed, Shelby D., Allen, Andrew S., Glendenning, G. Alastair, Schulman, Kevin A.

Volltext

Barriers to adherence of deferoxamine usage in sickle cell disease von Treadwell, Marsha J., Law, Amy W., Sung, Jennifer, Hackney-Stephens, Ekua, Quirolo, Keith, Murray, Eileen, Glendenning, G Alastair, Vichinsky, Elliott

Volltext

Quality of life on imatinib von Hahn, Elizabeth A., Glendenning, G.Alastair

Volltext

Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma von Reed, Shelby D, Radeva, Jasmina I, Glendenning, G Alastair, Coleman, Robert E, Schulman, Kevin A

Volltext

Cost-effectiveness of imatinib versus interferon-a plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia von REED, Shelby D, ANSTROM, Kevin J, LUDMER, Jennifer A, GLENDENNING, G. Alastair, SCHULMAN, Kevin A

Volltext

Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma von Higham, M A, Sharara, A M, Wilson, P, Jenkins, R J, Glendenning, G A, Ind, P W

Volltext